Back to Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 15

Modelling the Cost-Effectiveness of Indacaterol/Glycopyrronium versus Salmeterol/Fluticasone Using a Novel Markov Exacerbation-Based Approach

Total article views   HTML views PDF downloads Totals
3,353 Dovepress* 3,166+ 1,013 4,179
PubMed Central* 187 68 255
Totals 3,353 1,081 4,434
*Since 16 April 2020

View citations on PubMed Central and Google Scholar